Beloteca, Inc. Relocates Lab & Corporate Headquarters In San Diego, California
05/12/2017
The new facility currently spans more than 3,500 square feet and will expand to over 6,000 square feet. The larger space allows Beloteca's to increase its in-house product development capabilities and hire more employees in formulation and analytical development.
Beloteca currently has an active development pipeline with more than 15 pharmaceutical products in various stages of development.
According to company officials, the unification of the headquarters and laboratories will provide increased communication and collaboration between development and the other departments resulting in more efficient development of products.
"We are excited to have found this new location as it will enable Beloteca to continue to grow and internalize development over the next several years," said Fred Defesche, CEO of Beloteca, Inc. "The new space is ideal because it allows us to acquire additional space after obtaining approval of our first products without being encumbered by excess expenses while we are in our startup phase,” he added.
Project Announcements
Busch Vacuum Solutions Plans Tempe, Arizona, Operations
08/18/2025
Made Scientific Establishes Princeton, New Jersey, Manufacturing-Headquarters Operations
08/18/2025
Comcast Establishes West Palm Beach, Florida, Operations
08/17/2025
Buttonwood Farm Expands Fortuna, Missouri, Egg Production Operations
08/15/2025
MerryGoRound Plans Pittsylvania County, Virginia, Fulfillment Operations
08/14/2025
Hartman Cabinetry Plans Jonesburg, Missouri, Operations
08/14/2025
Most Read
-
What We’re Getting Wrong About Gen Z’s Future in the Skilled Trades
Q3 2025
-
A New Course for U.S. Shipbuilding
Q3 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
How to Choose the Right Site for Your Factory in 2025’s Volatile Landscape
Q2 2025
-
Reshoring Reality Check from Construction
Q3 2025
-
The New Math Behind Mexico and U.S. Manufacturing Decisions
Q2 2025